Wockhardt reports Q1 FY26 loss at Rs. 108 Cr
Consolidated revenue from operations in the quarter was marginally down at Rs 738 crore a
Consolidated revenue from operations in the quarter was marginally down at Rs 738 crore a
India Formulation sales accounted for 34.2% of total consolidated sales for the quarter
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
Ibrutinib tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
The coating is designed for heat-sealable applications, offering oil and grease resistance on kraft paper and suitable blister coatings for paper and paperboard
The audit has been concluded with no major observations
Granules India receives 1 observation from USFDA for Chantilly facility
Subscribe To Our Newsletter & Stay Updated